LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia.
LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia.
Continuation chemotherapy is a key component of the treatment of childhood acute lymphoblastic leukaemia. During this treatment phase, weekly dose adjustments are carried out based on current and historical full blood counts (FBCs). The dose decision pathway is complex and suboptimal therapy may result if information on FBC results is not readily available and/or the prescriber is inexperienced. A web-based decision-support system (Leukaemia Intervention Scheduling and Advice, ‘LISA’) was designed to facilitate access to FBC information across geographical locations and to assist with dosage adjustments. A balanced-block crossover analysis was performed to evaluate the system. Thirty-six clinicians with varying degrees of experience were each asked to decide on appropriate oral chemotherapy dosages for eight simulated cases: four using LISA and four without. LISA significantly reduced the number of erroneous prescriptions (zero of 144 with LISA vs. 54 of 144 without; P < 0·0001) without affecting the number of times subjects deliberately overrode the protocol (seven of 144 times using LISA and six of 144 without). Using LISA reduced the time taken by novices to reach a decision for each case but increased the time taken by experts. Thirty-five of 36 subjects said they would be likely to use the system if it were available. A system like LISA is likely to be acceptable to clinicians, and has the potential to increase protocol compliance and decrease prescribing errors while allowing clinicians to override the protocol in specific cases where sound reasons exist for doing so.
746-754
Bury, Jonathan
63d00f69-916f-4edc-b50a-bc5d916736cd
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Roy, Anindita
b8c12076-5001-4e9c-9893-633eb6c87bfb
Cheesman, Louise
c46f22f8-cd9a-47b1-bc90-06e7d9c4233c
Bradburn, Mike
1de9ef82-6406-4dcb-aa5a-037c5fca3898
Cross, Simon
a12c7819-7282-48f5-aff8-2cfac7ff7097
Fox, John
885420e6-81a0-44e9-9b82-e4683b6ba3c4
Saha, Vaskar
629475ea-2b52-410e-8564-a658ce0a811c
7 June 2005
Bury, Jonathan
63d00f69-916f-4edc-b50a-bc5d916736cd
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Roy, Anindita
b8c12076-5001-4e9c-9893-633eb6c87bfb
Cheesman, Louise
c46f22f8-cd9a-47b1-bc90-06e7d9c4233c
Bradburn, Mike
1de9ef82-6406-4dcb-aa5a-037c5fca3898
Cross, Simon
a12c7819-7282-48f5-aff8-2cfac7ff7097
Fox, John
885420e6-81a0-44e9-9b82-e4683b6ba3c4
Saha, Vaskar
629475ea-2b52-410e-8564-a658ce0a811c
Bury, Jonathan, Hurt, Chris, Roy, Anindita, Cheesman, Louise, Bradburn, Mike, Cross, Simon, Fox, John and Saha, Vaskar
(2005)
LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia.
British Journal of Haematology, 129 (6), .
(doi:10.1111/j.1365-2141.2005.05541.x).
Abstract
Continuation chemotherapy is a key component of the treatment of childhood acute lymphoblastic leukaemia. During this treatment phase, weekly dose adjustments are carried out based on current and historical full blood counts (FBCs). The dose decision pathway is complex and suboptimal therapy may result if information on FBC results is not readily available and/or the prescriber is inexperienced. A web-based decision-support system (Leukaemia Intervention Scheduling and Advice, ‘LISA’) was designed to facilitate access to FBC information across geographical locations and to assist with dosage adjustments. A balanced-block crossover analysis was performed to evaluate the system. Thirty-six clinicians with varying degrees of experience were each asked to decide on appropriate oral chemotherapy dosages for eight simulated cases: four using LISA and four without. LISA significantly reduced the number of erroneous prescriptions (zero of 144 with LISA vs. 54 of 144 without; P < 0·0001) without affecting the number of times subjects deliberately overrode the protocol (seven of 144 times using LISA and six of 144 without). Using LISA reduced the time taken by novices to reach a decision for each case but increased the time taken by experts. Thirty-five of 36 subjects said they would be likely to use the system if it were available. A system like LISA is likely to be acceptable to clinicians, and has the potential to increase protocol compliance and decrease prescribing errors while allowing clinicians to override the protocol in specific cases where sound reasons exist for doing so.
This record has no associated files available for download.
More information
Accepted/In Press date: 11 April 2005
e-pub ahead of print date: 7 June 2005
Published date: 7 June 2005
Identifiers
Local EPrints ID: 488294
URI: http://eprints.soton.ac.uk/id/eprint/488294
ISSN: 0007-1048
PURE UUID: 2d6c05e5-4355-485d-a0fa-fb19223f7125
Catalogue record
Date deposited: 19 Mar 2024 18:08
Last modified: 21 Mar 2024 03:14
Export record
Altmetrics
Contributors
Author:
Jonathan Bury
Author:
Chris Hurt
Author:
Anindita Roy
Author:
Louise Cheesman
Author:
Mike Bradburn
Author:
Simon Cross
Author:
John Fox
Author:
Vaskar Saha
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics